Pakistan’s pharmaceutical industry has witnessed a meteoric rise over the last decade, evolving from a domestic supply chain to a significant global exporter of injectable drugs. As a key destination for high-quality, cost-effective medicine, the country hosts over 700 pharmaceutical manufacturing units. The strategic focus on injectables—ranging from life-saving antibiotics to specialized veterinary solutions—has positioned Pakistan as a hub for healthcare procurement in South Asia and the Middle East.
Major industrial zones in Karachi, Lahore, and Faisalabad are now equipped with state-of-the-art sterile manufacturing facilities that comply with the Drug Regulatory Authority of Pakistan (DRAP) and international GMP standards. This growth is bolstered by the China-Pakistan Economic Corridor (CPEC), which has facilitated smoother logistics and technology transfers in the biochemical sector.
The industry is shifting toward fully automated fill-finish lines for injectables, reducing human error and ensuring 100% sterility, which is crucial for retinal and ophthalmic surgery drugs.
Pakistan is increasing its focus on biosimilars and complex injectables. We provide the raw materials and intermediates necessary for this high-tech transition.
Utilizing AI-driven data analytics to manage temperature-sensitive injectable logistics, ensuring that room-temperature and cold-chain products reach clinics in perfect condition.
With Pakistan's massive livestock sector, the demand for veterinary injectables like Ivermectin and Amoxicillin has surged, leading to specialized export-grade production lines.
Hangzhou Jeci Biochem Technology Co., Ltd. is a leading force in the biochemical industry. Located in the innovation hub of Hangzhou, Zhejiang Province, we specialize in the sales of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and high-end nutritional products.
Our collaborative R&D team works closely with top-tier research institutes to provide custom manufacturing and technology transfer services. For the Pakistani market, we act as a bridge, providing the essential chemical materials and pharmaceutical intermediates required for local injectable drug production.
Clinical diagnosis utilizing Indocyanine Green for bile leakage observation and liver segment detection in leading hospitals like AKU.
Mass vaccination and treatment programs using Buparvaquone and Amoxicillin injections for cattle and sheep health management.
Specialized ophthalmic clinics requiring disposable injectable drugs for retinal surgery with effortless storage solutions.
Supplying essential antibiotics like Penicillin G Procaine to rural healthcare centers across Sindh and Balochistan.
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization.
For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
As we look toward 2025, the synergy between Chinese technological expertise and Pakistan's industrial capacity is set to redefine the pharmaceutical landscape. Our commitment as a leading injectable drugs supplier and exporter is to ensure that healthcare providers in Pakistan have access to the highest quality drugs, from retinal surgery aids to life-sustaining veterinary medicines.
We provide comprehensive services including product registration, consulting, and sales channel expansion for overseas companies looking to enter the Pakistani market, while simultaneously empowering local manufacturers with premium APIs and intermediates. Through rigorous quality management system certification and a robust international trade network involving India, Southeast Asia, Korea, and Japan, Hangzhou Jeci Biochem Technology remains your trusted partner in the global pharmaceutical supply chain.
SJ medical
